Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Delate

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
JAMA Internal Medicine|May 27, 2015
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive ProceduresNathan P Clark, Daniel M Witt, Loren E Davies, et al.
Thrombosis Research|February 14, 2014
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomesDaniel M Witt, Thomas Delate, Elaine M Hylek, et al.
JAMA Internal Medicine|January 22, 2014
Warfarin interactions with antibiotics in the ambulatory care settingNathan P Clark, Thomas Delate, Catherine S Riggs, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2012
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research networkDebra P Ritzwoller, Nikki M Carroll, Thomas Delate, et al.
Thrombosis Research|October 12, 2015
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhageDaniel M Witt, Nathan P Clark, Kerri Martinez, et al.
Clinical Lung Cancer|September 18, 2016
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung CancerAlex R Menter, Nikki M Carroll, Lori C Sakoda, et al.
Medical Care|April 26, 2012
Validation of electronic data on chemotherapy and hormone therapy use in HMOsDebra P Ritzwoller, Nikki Carroll, Thomas Delate, et al.
Health Services Research|August 7, 2021
Aligning care with the personal values of patients with complex care needsLeah Tuzzio, Andrew L Berry, Kathy Gleason, et al.
JAMA Network Open|March 19, 2026
Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical TrialDaniel M Witt, Heeseung Hong, Aaron S Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 17, 2012
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposureThomas Delate, Erin J Aiello Bowles, Roy Pardee, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
JAMA Internal Medicine|May 27, 2015
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive ProceduresNathan P Clark, Daniel M Witt, Loren E Davies, et al.
Thrombosis Research|February 14, 2014
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomesDaniel M Witt, Thomas Delate, Elaine M Hylek, et al.
JAMA Internal Medicine|January 22, 2014
Warfarin interactions with antibiotics in the ambulatory care settingNathan P Clark, Thomas Delate, Catherine S Riggs, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2012
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research networkDebra P Ritzwoller, Nikki M Carroll, Thomas Delate, et al.
Thrombosis Research|October 12, 2015
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhageDaniel M Witt, Nathan P Clark, Kerri Martinez, et al.
Clinical Lung Cancer|September 18, 2016
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung CancerAlex R Menter, Nikki M Carroll, Lori C Sakoda, et al.
Medical Care|April 26, 2012
Validation of electronic data on chemotherapy and hormone therapy use in HMOsDebra P Ritzwoller, Nikki Carroll, Thomas Delate, et al.
Health Services Research|August 7, 2021
Aligning care with the personal values of patients with complex care needsLeah Tuzzio, Andrew L Berry, Kathy Gleason, et al.
JAMA Network Open|March 19, 2026
Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical TrialDaniel M Witt, Heeseung Hong, Aaron S Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 17, 2012
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposureThomas Delate, Erin J Aiello Bowles, Roy Pardee, et al.
Pageof 16